Keep Up With McLean!
Receive the latest news in your inbox each month.
Available with English captions.
Carol Aboud, PharmD, RPh, Andrew Karas, PharmD, BCPP, David Snyder, PharmD, BCPP, McLean Hospital
Gabapentin, a synthetic analog of gamma-aminobutyric acid, was originally FDA-approved for use as an anticonvulsant. Due to a varied number of off-label uses and a mild side-effect profile at clinically appropriate doses, gabapentin’s use in the United States has expanded dramatically over the last decade. This has led to an increase in gabapentin misuse at high doses and especially in combination with other prescription and illicit substances.
Lecture highlights include:
SeriesGrand Rounds Lectures
Back to top